Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Current Assets (2016 - 2025)

Apyx Medical's Current Assets history spans 16 years, with the latest figure at $58.5 million for Q4 2025.

  • For Q4 2025, Current Assets rose 3.6% year-over-year to $58.5 million; the TTM value through Dec 2025 reached $58.5 million, up 3.6%, while the annual FY2025 figure was $58.5 million, 3.6% up from the prior year.
  • Current Assets reached $58.5 million in Q4 2025 per APYX's latest filing, up from $48.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $70.4 million in Q4 2023 to a low of $43.0 million in Q4 2022.
  • Average Current Assets over 5 years is $55.1 million, with a median of $53.8 million recorded in 2022.
  • Peak YoY movement for Current Assets: fell 29.25% in 2022, then soared 63.74% in 2023.
  • A 5-year view of Current Assets shows it stood at $60.7 million in 2021, then fell by 29.25% to $43.0 million in 2022, then skyrocketed by 63.74% to $70.4 million in 2023, then dropped by 19.79% to $56.4 million in 2024, then grew by 3.6% to $58.5 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Current Assets are $58.5 million (Q4 2025), $48.8 million (Q3 2025), and $49.9 million (Q2 2025).